Study of the effect of standardized chemotherapy order forms on prescribing errors and anti-emetic cost

Author:

Sano Harold S1,Waddell J Aubrey1,A Solimando Dominic2,Doulaveris Paula3,Myhand Rickey4

Affiliation:

1. Hematology-Oncology Service, Department of Pharmacy, Walter Reed Army Medical Center, Washington, DC, USA

2. Hematology-Oncology Service, Department of Pharmacy, Walter Reed Army Medical Center, Washington, DC, USA, Oncology Pharmacy Services, Inc., Arlington, VA, USA

3. Hematology-Oncology Service, Department of Pharmacy, Walter Reed Army Medical Center, Washington, DC, USA, US Army Medical Material Center-Southwest Asia (USAMMC-SWA), Qatar

4. Hematology-Oncology Service, Department of Pharmacy, Walter Reed Army Medical Center, Washington, DC, USA, Hematology-Oncology Service, Department of Medicine, Brooke Army Medical Center, Ft. Sam Houston, TX, USA

Abstract

Objectives. Many anti-neoplastic medication errors and excessive use of serotonin antagonist anti-emetic agents might be prevented by the use of a standardized chemotherapy order form (SCOF). Several studies showing a reduction in prescribing errors or control of inappropriate anti-emetic use through the use of SCOFs have been reported. No previously published study reported SCOFs were used to reduce both prescribing errors and anti-emetic cost. This study attempts to measure these outcomes in a haematology-oncology pharmacy service. Methods. The study consisted of a four-month control period, followed by a four-month test period following dissemination of the standardized order forms. In each period, prescriber errors and anti-emetic use were monitored. During the control period, using clinical studies from the primary literature and anti-emetic guidelines, 64 SCOFs representing the most commonly used chemotherapy regimens in the medical oncology and gynaecology oncology services were developed by the haematology-oncology pharmacy. Differences in prescribing error rate and anti-emetic cost were compared between each period and with the institution’s historic prescribing error rate. Results. During the control period, 1078 orders for oral and parenteral granisetron and ondansetron with combined total acquisition cost of $76 454.64 and a mean cost of $70.92 were dispensed. During the test period, the pharmacy dispensed 1121 orders with an acquisition cost of $73 331.61 and a mean cost of $65.42. A savings of $3123.03 resulted from a reduction of the amount prescribed in the test period. The difference in mean cost per order between the two periods was significant (P B0.037). Fifty-three prescribing errors out of 3592 medication orders were detected in the control period, while 12 errors out of 3585 medication orders were detected during the test period. A significant difference (P B0.0001) was detected between the two periods. There was a significant difference (P B0.0001) between the control period and the institution’s historic prescribing error rate and no difference between the test period and the institution’s historic prescribing error rate. Conclusion. SCOFs significantly reduced serotonin antagonist anti-emetic cost and prescribing error rate over a four-month period.

Publisher

SAGE Publications

Subject

Pharmacology (medical),Oncology

Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3